162170-49-2

Basic information

• Product Name: 3-(α-cyclopropyl-meta-(benzyloxycarbonylamino)benzyl)-6-(α-ethyl-phenethyl)-4-hydroxy-2H-pyran-2-one
• Synonyms: 3-(α-cyclopropyl-meta-(benzyloxycarbonylamino)benzyl)-6-(α-ethyl-phenethyl)-4-hydroxy-2H-pyran-2-one
• CAS NO: 162170-49-2
• Molecular Weight: 523.629
• Mol File: 162170-49-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3-(α-cyclopropyl-meta-(benzyloxycarbonylamino)benzyl)-6-(α-ethyl-phenethyl)-4-hydroxy-2H-pyran-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(α-cyclopropyl-meta-(benzyloxycarbonylamino)benzyl)-6-(α-ethyl-phenethyl)-4-hydroxy-2H-pyran-2-one(162170-49-2)
• EPA Substance Registry System: 3-(α-cyclopropyl-meta-(benzyloxycarbonylamino)benzyl)-6-(α-ethyl-phenethyl)-4-hydroxy-2H-pyran-2-one(162170-49-2)

Safety Data

• Hazardous Substances Data: 162170-49-2(Hazardous Substances Data)

Upstream product

• 162174-75-6 cyclopropyl-(3-aminophenyl)methanone 
• 501-53-1 benzyl chloroformate 
• 100-39-0 benzyl bromide 
• 162174-76-7 meta-Benzyloxycarbonylaminophenyl cyclopropyl ketone 
• 3481-02-5 cyclopropyl phenyl ketone 
• 33253-32-6 4-Hydroxy-6-phenethyl-2-pyrone 
• 174485-05-3 3-(α-Cyclopropyl-meta-(benzyloxycarbonylamino)benzyl)-4-hydroxy-6-methyl-pyran-2-one 
• 162174-77-8 m-<(benzyloxycarbonyl)amino>phenyl cyclopropyl carbinol 
• 675-10-5 4-hydroxy-6-methyl-2-pyron 
• 162174-71-2 6-(α-ethyl-phenethyl)-4-hydroxy-2H-pyran-2-one 
• 2021-28-5 ethyl dihydrocinnamate 
• 5680-51-3 cyclopropyl-(3-nitrophenyl)methanone 
• 174485-06-4 3-(α-Cyclopropyl-meta-(benzyloxycarbonylamino)benzyl)-4-hydroxy-6-propyl-pyran-2-one 

Downstream Products

• 162169-82-6 3-(α-cyclopropyl-meta-(4-cyanophenylsulfonylamino)benzyl)-6-(α-ethylphenethyl)-4-hydroxy-2H-pyran-2-one 
• 162174-72-3 3-(α-cyclopropyl-meta-aminobenzyl)-6-(α-ethyl-phenethyl)-4-hydroxy-2H-pyran-2-one 

Relevant articles and documents

Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases

Certain 2H-pyran-2-ones are useful for treating benign prostatic hypertrophy or hyperplasia, prostatic cancer, alopecia, hirsutism, acne vulgaris and seborrhea.

Structure-based design of novel HIV protease inhibitors: Sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitors

The low oral bioavailability and rapid biliary excretion of peptide-derived HIV protease inhibitors have limited their utility as potential therapeutic agents. Our broad screening program to discover non-peptidic HIV protease inhibitors previously identif